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the mean total histological score, as well as with medial com- 
partment score (p=0.028, r=0.859 and p=0.033, r=0.847, respec- 
tively). Steady-state mRNA levels of FXlIIA were not detectable 
in either the medial or the lateral compartment until 12 months 
of age, when a low level of expression was detected in the me- 
dial compartment. Concentrations of TG2 in guinea pig synovial 
fluid rose steadily from 7 to 12 months of age and correlated 
significantly with total histological score (p=0.03, r=0.46). TG2 
concentrations also correlated strongly with synovial fluid COMP 
(p=0.05, r=0.39). The association of TG2 with histological out- 
come remained significant after adjusting for the effects of age, 
weight, and COMP. There was no significant change in the levels 
of SF FXlIIA with age, as well as no correlation with total histo- 
logical score. 
Conclusions: Our results reveal that TG2, but not FXlIIA mRNA 
expression and synovial fluid protein concentrations, reflect his- 
tological OA in the guinea pig model as well as disease pro- 
gression. These findings are consistent with the proposed role 
of TG2 in OA pathogenesis via effects on chondrocyte differenti- 
ation. TG2, expressed by chondrocytes in situ and released into 
the synovial fluid, also serves as a novel and TG family-specific 
biomarker of OA development and progression. 
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TURNOVER OF SYNOVIAL FLUID HYALURONAN: A 
POTENTIAL KINETIC BIOMARKER OF EARLY 
OSTEOARTH RITIS 
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The aim of this study was to measure hyaluronic acid (HA) 
turnover in the synovial fluid of normal and degenerate knee joints 
using a novel in vivo labeling method. 
Newly-synthesized HA was labeled in experimental animals by 
administering water enriched with 2H20 , first as an IP injection, 
then as drinking water. Following 24 hours of labeling, synovial 
fluid was collected from the knee joints by lavage, and the HA was 
isolated and analyzed by gas chromatography mass spectrome- 
try. The fraction of synovial fluid HA that was newly-synthesized 
was determined from the incorporation of 2H into N-acetyl glu- 
cosamine. Three animal models of osteoarthritis (OA) were used. 
Guinea pigs were analyzed both at a young age (2 months old) 
and after the onset of spontaneous OA (12 months old). Also, 
experimental OA was induced in one knee of rats by either a sin- 
gle intra-articular injection of the glycolysis inhibitor, monoiodoac- 
etate, or by meniscal tear surgery. Rats were analyzed five days 
after treatment, at which point, degenerative changes could be 
observed histologically. Contralateral knees were used as con- 
trols. 
In all cases, the fractional synthesis of synovial fluid HA was 
higher in aged or treated joints (Fig. 1). 724-8% of synovial fluid 
HA was turned over during the 24 hour labeling period in young 
guinea pigs, whereas older guinea pigs had a fractional synthe- 
sis of 874-7% (n=5-6, p<0.01 ). Monoiodoacetate (MIA) treatment 
led to an 16% increase in the fractional synthesis of the HA in 
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Fig. 1. Effect of experimentally induced OA on fractional synthesis of HA in 
the synovial fluid of the degenerate knee joint. 
the synovial fluid (n=3, p<0.01). Similarly, knees subjected to 
meniscal tear surgery (MNX) exhibited a fractional synthesis of 
HA of 704-1.3%, compared to control knees which had a frac- 
tional synthesis of 564-1.6% (n=2), although the differences were 
not statisically significant (p=0.1). 
The results of this study suggest a correlation between the os- 
teoarthritic hanges induced in these animal models and an in- 
crease in the turnover of the hyaluronan component of the syn- 
ovial fluid in the affected joint. Such an increase in HA may be 
due, in part, to the onset of synovitis, a common feature of os- 
teoarthritis. Indeed, our results may support clinical observations 
that synovitis correlates with OA progression. Since this method 
requires only a representative sampling of synovial fluid, it could 
provide a minimally invasive index of disease progression in hu- 
mans. 
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Aim of Study: Osteoarthritis (OA) is a degenerative joint disease 
characterized by progressive erosion of articular cartilage. Aggre- 
can is an important component of the extracellular matrix and so 
the monitoring of its degradation and formation could be useful in 
monitoring disease activity or the efficacy of treatment with chon- 
droprotective agents. The aim of the present study was to inves- 
tigate the potential of two newly developed immunoassays for the 
assessment of aggrecan metabolism under various experimental 
conditions. 
Methods: Ex vivo cartilage explants were cultured under serum- 
free conditions with either 1) no cytokines, 2) with the cy- 
tokines oncostatin M (OSM) and TNF~, or 3) with the aforemen- 
tioned cytokines plus an MMP-inhibitor, GM6001 101~M. For refer- 
ence purposes, metabolically inactivated cartilage explants were 
also included. The culture medium was replaced every 2nd-3  rd 
day, and assessed for changes in aggrecan metabolism. Aggre- 
can turnover was characterized by two independently developed 
sandwich immuno-assays: 1) Assay G2 employs a monoclonal 
antibody (F78) specific for the G2 domain of aggrecan, 2) Assay 
FFGVG-G2 combining the F78 antibody with a monoclonal anti- 
body (AF28) targeting the epitope 342FFGVG, which is generated 
during MMP digestion at the cleavage site VDIPEN-FFGVG in the 
interglobular domain of aggrecan. 
Results: Ex vivo cartilage explants were exposed to OSM and 
TNF-~ to induce cartilage degradation, which was accompanied 
by a gradual increase in the concentration of FFGVG-G2 from 
day Day 12 (Fig. 1). When the exposure of explants occurred in 
the concomitant presence of GM6001, the release of FFGVG-G2 
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was completely inhibited. Under the same experimental condi- 
tions, changes in the total release of G2 domain measured by the 
G2 assay showed a different profile. There was an initial increase 
between days 2 and 5 followed by a progressive decline reaching 
detection limit by day 12 (Fig. 1 ). The addition of GM6001 did not 
have any influence on the course of this curve. 
Conclusion: These results suggest that the herein introduced 
sandwich immuno-assays G2 and FFGVG-G2 allow the assess- 
ment of separate processes of aggrecan metabolism in articular 
cartilage. Whereas the monitoring of FFGVG-G2 reflect aggrecan 
degradation, further studies are needed to clarify which aspects 
of aggrecan turnover are reflected by the changes in the total re- 
lease of the G2 domain from the explant cultures. The herein pre- 
sented assays carry noteworthy potentials to become useful tools 
for monitoring disease processes and the effects of interventions. 
P63 
SIMULTANEOUS MEASUREMENT OF CELL AND MATRIX 
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While a homeostatic balance between matrix synthesis and 
degradation is maintained in healthy cartilage, metabolic pro- 
cesses are modulated in osteoarthritis to favor catabolism. In this 
study, a novel biochemical method for measuring aspects of cell 
and matrix turnover using a single stable isotope precursor was 
validated and used to profile metabolic changes in animal and 
tissue culture models of cartilage degeneration. 
Bovine cartilage explants were maintained with medium including 
I L-1. For in vivo studies, degeneration was induced in rat knees by 
either chemical (monoiodoacetate) or mechanical (meniscal tear) 
interventions. Cartilage degeneration was confirmed by quantify- 
ing the release of sulfated GAG into culture medium or by his- 
tological analysis. To label newly-synthesized metabolites, 2H20 
was administered via either culture medium or drinking water. 
After isolation of DNA and chondroitin sulfate (CS) from carti- 
lage samples, the 2 H enrichments were quantified by GC/MS and 
used to calculate fractional de novo synthesis. 
Cartilage explants analyzed after 5 days in serum-supplemented 
culture had fractional CS synthesis of 134-2% (2.64-0.4%/day; 
n=4). This was comparable to the rate at which GAG was re- 
leased into the medium (2.3%/day). The inclusion of IL-1 inhibited 
the rate of CS turnover dose-dependently (Fig. 1A). Chondrocyte 
turnover (1.14-0.5%/day; n=16) also was inhibited by IL-1 (Fig. 
1B). 
MIA-treated rat knees developed regions of cartilage matrix loss 
and decreased cell viability 5 days after injection, and the de- 
generation progressively worsened. However, CS turnover in the 
cartilage from the affected knee remained indistinguishable from 
control knees until 9 days post-injection (Fig. 2). Rat knees in 
which the medial meniscus was torn exhibited gross degenera- 
tive changes earlier, within 3 days of surgery. CS synthesis was 
elevated with the onset of cartilage degeneration (day 3) relative 
to control knees, returning to control levels by day 9 (Fig. 3). In 
both forms of experimental OA, the degenerating cartilage exhib- 
ited a period of marked stimulation in CS turnover (~2X of con- 
trol), but this increase occurred on different timecourses. While 
the physiological implication of this is as yet unclear, it is evident 
that changes in CS synthesis rates are detectable in vivo and are 
modulated in both physical and chemical models of OA. 
This stable isotope/mass pectrometry approach can be used to 
measure turnover of other matrix constituents. Preliminary mea- 
surements indicate that in normal rat cartilage, collagen turns 
over at a rate of 1-3%/day. Thus, the method is robust, allowing 
multiple, simultaneous measurements from a single specimen of 
cartilage. The ability to evaluate cell-mediated alterations during 
OA progression in vitroand in vivois appealing in small animal ex- 
perimentation but may also have significant clinical applications. 
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Introduction: Helix-II and CTX-II are type II collagen degradation 
markers recognizing specific sequences from the helical and C- 
telopeptide domains of type II collagen, respectively. Both mak- 
ers are elevated in urine of patients with osteoarthritis (OA) or 
rheumatoid arthritis (RA). However, in these clinical conditions, 
Helix-II and CTX-II correlate only moderately with each other, 
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